INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 67 filers reported holding INHIBRX INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $593,219 | -87.3% | 32,328 | -82.1% | 0.00% | -100.0% |
| Q2 2023 | $4,681,834 | +34381.0% | 180,348 | -74.9% | 0.00% | -75.0% |
| Q1 2023 | $13,578 | -24.3% | 719,553 | -1.2% | 0.01% | -20.0% |
| Q4 2022 | $17,944 | -99.8% | 728,236 | +22.1% | 0.01% | +66.7% |
| Q3 2022 | $10,706,000 | -0.4% | 596,426 | -37.0% | 0.01% | -14.3% |
| Q2 2022 | $10,749,000 | +550.3% | 947,031 | +1808.0% | 0.01% | +600.0% |
| Q3 2021 | $1,653,000 | -81.1% | 49,634 | -84.4% | 0.00% | -80.0% |
| Q2 2021 | $8,735,000 | +424.3% | 317,401 | +282.3% | 0.01% | +400.0% |
| Q1 2021 | $1,666,000 | -30.1% | 83,018 | +14.8% | 0.00% | -50.0% |
| Q4 2020 | $2,384,000 | +95.7% | 72,304 | +6.8% | 0.00% | +100.0% |
| Q3 2020 | $1,218,000 | – | 67,676 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
| Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
| RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
| Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
| Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
| Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
| VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
| Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
| Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
| ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |